COVID-19–associated mucormycosis: a systematic review and meta-analysis of 958 cases

COVID-19 associated mucormycosis – An emerging threat

(2022) Chien-Ming Chao et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

(2022) Martin Hoenigl et al.   Lancet Microbe

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

(2021) Juergen Prattes et al.   CLINICAL MICROBIOLOGY AND INFECTION

ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries

(2021) Shivaprakash M. Rudramurthy et al.   MYCOSES

Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?

(2021) Akshay Raut et al.   Lancet Respiratory Medicine

Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study

(2021) Jean-Pierre Gangneux et al.   Lancet Respiratory Medicine

An aero mycological analysis of Mucormycetes in indoor and outdoor environments of northern India

(2019) Hariprasath Prakash et al.   MEDICAL MYCOLOGY

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

(2019) Oliver A Cornely et al.   LANCET INFECTIOUS DISEASES

The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports

(2018) Wirawan Jeong et al.   CLINICAL MICROBIOLOGY AND INFECTION

OUP accepted manuscript

(2018)   MEDICAL MYCOLOGY

Mucormycosis in Australia: contemporary epidemiology and outcomes

(2016) K.J. Kennedy et al.   CLINICAL MICROBIOLOGY AND INFECTION

Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data

(2015) Lesley A. Stewart et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Epidemiology of mucormycosis in Europe

(2014) G. Petrikkos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Epidemiology and Clinical Manifestations of Mucormycosis

(2012) George Petrikkos et al.   CLINICAL INFECTIOUS DISEASES

A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)

(2012) F. Lanternier et al.   CLINICAL INFECTIOUS DISEASES

Pathogenesis of Mucormycosis

(2012) Ashraf S. Ibrahim et al.   CLINICAL INFECTIOUS DISEASES

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

(2011) A. Skiada et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Order Mucorales

(2011) Roxana G. Vitale et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In vitro activity of antifungals against Zygomycetes

(2009) A. Alastruey-Izquierdo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Changing epidemiology of an emerging infection: zygomycosis

(2009) J.F. Meis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?

(2009) G.N. Pongas et al.   CLINICAL MICROBIOLOGY AND INFECTION

Invasive zygomycosis in India: experience in a tertiary care hospital

(2009) A Chakrabarti et al.   POSTGRADUATE MEDICAL JOURNAL